Skip to content
Open access · CC-BY via OpenAlex

α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression

Jing Qian, Jianyong Zhong, Shaojun Liu, Minhua Yan, Ping Cheng, Chuan‐Ming Hao, Yong Gu, Lingyun Lai

Kidney Medicine · 2021 · ▲ 4 citations

Abstract

Rationale & Objective We aimed to explore the associated factors of endothelial injury in chronic kidney disease (CKD) and the relationship between endothelial dysfunction and CKD prognosis. Study Design A prospective observational cohort study. Setting & Participants 77 adults with CKD stages 1-5 were enrolled January 2010 to December 2010 and followed up until December 2015. Exposure Serum asymmetric dimethylarginine (ADMA) level at baseline, α-klotho, sodium-phosphorus synergistic transporter, and dimethylarginine-dimethylamine hydrolase expression in kidney biopsy samples. Outcome Initiation of kidney replacement therapy (KRT). Analytical Approach Kaplan-Meier analysis was used for evaluation of the incidence rate of KRT. All tests were 2 tailed, and statistical significance was defined as P <0.05. Results Mean serum ADMA level of 77 patients was 64.3±34.6ng/mL. ADMA level increased with CKD stages ( P =0.06) and declining kidney function ( r =−0.267; P =0.02). The expression of α-klotho in kidney biopsy specimens also decreased. Median follow-up time was 56 (interquartile range, 50.5-62) months. Kaplan-Meier analyses showed that during a total follow-up of 6 years, the incidence of KRT initiation in the high-ADMA group was significantly higher than that in the low group (35.9% vs 13.2%; P =0.03). ADMA level was negatively correlated with α-klotho ( r =−0.233; P =0.04) and positively correlated with phosphorus level ( r =0.243; P =0.04). The expression of sodium-phosphorus synergistic transporter in kidney tubules, which promoted phosphorus reabsorption, and the expression of dimethylarginine-dimethylamine hydrolase isoform 1, which regulated ADMA, were decreased. Correlation analysis also showed that ADMA level decreased while age increased at baseline ( r =−0.292; P = 0.01). Limitations Small sample size with limited longer-term follow-up. Conclusions Serum ADMA levels increased as kidney function declined, and high serum ADMA level was associated with incident kidney failure. Low tissue α-klotho and high levels of plasma phosphorus or tissue expression of type II sodium/phosphate cotransporter in the kidney are associated with higher circulating ADMA levels, suggesting that they may be involved in the pathogenesis of endothelial dysfunction in patients with CKD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.xkme.2021.05.008
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Qian, J., Zhong, J., Liu, S., Yan, M., Cheng, P., Hao, C., Gu, Y., &amp; Lai, L. (2021). α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression. <em>Kidney Medicine</em>. https://doi.org/10.1016/j.xkme.2021.05.008
Vancouver
Qian J, Zhong J, Liu S, Yan M, Cheng P, Hao C, et al. α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression. Kidney Medicine. 2021. doi:10.1016/j.xkme.2021.05.008.
BibTeX
@article{jing2021Klotho, title = {α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression}, author = {Jing Qian and Jianyong Zhong and Shaojun Liu and Minhua Yan and Ping Cheng and Chuan‐Ming Hao and Yong Gu and Lingyun Lai}, journal = {Kidney Medicine}, year = {2021}, doi = {10.1016/j.xkme.2021.05.008}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings